Cryo-Cell International Statistics
Total Valuation
CCEL has a market cap or net worth of $27.95 million. The enterprise value is $35.77 million.
Important Dates
The last earnings date was Tuesday, April 14, 2026, after market close.
| Earnings Date | Apr 14, 2026 |
| Ex-Dividend Date | May 21, 2025 |
Share Statistics
CCEL has 8.06 million shares outstanding. The number of shares has decreased by -1.46% in one year.
| Current Share Class | 8.06M |
| Shares Outstanding | 8.06M |
| Shares Change (YoY) | -1.46% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 40.01% |
| Owned by Institutions (%) | 7.13% |
| Float | 4.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 34.70 |
| PS Ratio | 0.89 |
| Forward PS | 0.93 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 5.66 |
| P/OCF Ratio | 5.40 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 30.49, with an EV/FCF ratio of 7.24.
| EV / Earnings | n/a |
| EV / Sales | 1.14 |
| EV / EBITDA | 30.49 |
| EV / EBIT | 186.75 |
| EV / FCF | 7.24 |
Financial Position
The company has a current ratio of 0.62
| Current Ratio | 0.62 |
| Quick Ratio | 0.55 |
| Debt / Equity | n/a |
| Debt / EBITDA | 6.56 |
| Debt / FCF | 2.17 |
| Interest Coverage | 0.09 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 0.19% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 0.44% |
| Weighted Average Cost of Capital (WACC) | 9.74% |
| Revenue Per Employee | $411,586 |
| Profits Per Employee | -$35,068 |
| Employee Count | 76 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 20.98 |
Taxes
| Income Tax | -135,430 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.26% in the last 52 weeks. The beta is 0.63, so CCEL's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | -38.26% |
| 50-Day Moving Average | 3.38 |
| 200-Day Moving Average | 4.01 |
| Relative Strength Index (RSI) | 48.30 |
| Average Volume (20 Days) | 10,719 |
Short Selling Information
The latest short interest is 9,453, so 0.12% of the outstanding shares have been sold short.
| Short Interest | 9,453 |
| Short Previous Month | 9,397 |
| Short % of Shares Out | 0.12% |
| Short % of Float | 0.23% |
| Short Ratio (days to cover) | 0.47 |
Income Statement
In the last 12 months, CCEL had revenue of $31.28 million and -$2.67 million in losses. Loss per share was -$0.33.
| Revenue | 31.28M |
| Gross Profit | 19.87M |
| Operating Income | 191,517 |
| Pretax Income | -2.80M |
| Net Income | -2.67M |
| EBITDA | 1.17M |
| EBIT | 191,517 |
| Loss Per Share | -$0.33 |
Full Income Statement Balance Sheet
The company has $2.90 million in cash and $10.71 million in debt, giving a net cash position of -$7.81 million or -$0.97 per share.
| Cash & Cash Equivalents | 2.90M |
| Total Debt | 10.71M |
| Net Cash | -7.81M |
| Net Cash Per Share | -$0.97 |
| Equity (Book Value) | -18.40M |
| Book Value Per Share | -2.28 |
| Working Capital | -6.69M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $5.18 million and capital expenditures -$235,487, giving a free cash flow of $4.94 million.
| Operating Cash Flow | 5.18M |
| Capital Expenditures | -235,487 |
| Depreciation & Amortization | 981,444 |
| Net Borrowing | -3.12M |
| Free Cash Flow | 4.94M |
| FCF Per Share | $0.61 |
Full Cash Flow Statement Margins
Gross margin is 63.53%, with operating and profit margins of 0.61% and -8.52%.
| Gross Margin | 63.53% |
| Operating Margin | 0.61% |
| Pretax Margin | -8.95% |
| Profit Margin | -8.52% |
| EBITDA Margin | 3.75% |
| EBIT Margin | 0.61% |
| FCF Margin | 15.80% |